Section of Psychiatry, Department of Medicine and Surgery, University of Perugia, Piazzale Lucio Severi 1, 06132 Perugia, Italy.
Section of Neurology, Department of Medicine and Surgery, University of Perugia, Piazzale Gambuli 1, 06132 Perugia, Italy.
Int J Mol Sci. 2021 Apr 23;22(9):4440. doi: 10.3390/ijms22094440.
Different psychopathological manifestations, such as affective, psychotic, obsessive-compulsive symptoms, and impulse control disturbances, may occur in most central nervous system (CNS) disorders including neurodegenerative and neuroinflammatory diseases. Psychiatric symptoms often represent the clinical onset of such disorders, thus potentially leading to misdiagnosis, delay in treatment, and a worse outcome. In this review, psychiatric symptoms observed along the course of several neurological diseases, namely Alzheimer's disease, fronto-temporal dementia, Parkinson's disease, Huntington's disease, and multiple sclerosis, are discussed, as well as the involved brain circuits and molecular/synaptic alterations. Special attention has been paid to the emerging role of fluid biomarkers in early detection of these neurodegenerative diseases. The frequent occurrence of psychiatric symptoms in neurological diseases, even as the first clinical manifestations, should prompt neurologists and psychiatrists to share a common clinico-biological background and a coordinated diagnostic approach.
不同的精神病理学表现,如情感、精神病、强迫症状和冲动控制障碍,可能发生在大多数中枢神经系统(CNS)疾病中,包括神经退行性和神经炎性疾病。精神症状通常代表这些疾病的临床发作,因此可能导致误诊、治疗延迟和预后更差。在这篇综述中,讨论了几种神经系统疾病(即阿尔茨海默病、额颞叶痴呆、帕金森病、亨廷顿病和多发性硬化症)过程中观察到的精神症状,以及涉及的大脑回路和分子/突触改变。特别关注了液体生物标志物在这些神经退行性疾病早期检测中的新作用。精神症状在神经系统疾病中频繁发生,即使作为首发临床表现,也应促使神经科医生和精神科医生共享共同的临床生物学背景和协调的诊断方法。